3D QSAR Studies on Substituted Benzimidazole Derivatives as Angiotensin II-AT1 Receptor Antagonist

By  

Current Computer - Aided Drug Design, Vol. 9, Iss. 3, 2013-09 ,pp. : 433-445

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and angiotensin II receptor antagonist activity of C-linked pyrimidine derivatives

By Nicolai E.   Cure G.   Goyard J.   Kirchner M.   Teulon J.   Versigny A.   Cazes M.   Virone-Oddos A.   Caussade F.   Cloarec A.  

European Journal of Medicinal Chemistry, Vol. 30, Iss. 5, 1995-01 ,pp. : 365-375

Elsevier

Access to resources Recommend Favorite

Nonpeptide angiotensin II receptor antagonist recognizes inter-species differences in angiotensin AT 1 receptors

By Kawano K.-i.   Fujishima K.   Nagura J.   Yasuda S.   Shinki   Hachisu M.   Konno F.  

European Journal of Pharmacology, Vol. 357, Iss. 1, 1998-09 ,pp. : 33-39

Elsevier

Access to resources Recommend Favorite

Valsartan: a novel angiotensin Type 1 receptor antagonist

By Thürmann P.A.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. : 337-350

Informa Healthcare

Access to resources Recommend Favorite

Comparative effects of tamoxifen and angiotensin II type-1 receptor antagonist therapy on the hemodynamic profile of the ovariectomized female rat

By Pham-Dang My-Lan   Clement Robert   Mercier Isabelle   Calderone Angelino  

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 9, 2003-09 ,pp. : 915-919

NRC Research Press

Access to resources Recommend Favorite